Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
16.10
-0.68 (-4.05%)
At close: Oct 30, 2026, 4:00 PM EST
16.10
0.00 (0.00%)
Pre-market: Nov 2, 2026, 5:48 AM EST
Ultragenyx Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $36 | Buy | Maintains | $36 | +123.60% | Oct 21, 2026 |
| UBS | UBS | Hold Initiates $16 | Hold | Initiates | $16 | -0.62% | Oct 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +55.28% | Oct 14, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $20 | Hold | Maintains | $20 | +24.22% | Oct 9, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $19 | Hold | Maintains | $19 | +18.01% | Oct 9, 2026 |
| Evercore ISI | Evercore ISI | Hold Maintains $16 → $18 | Hold | Maintains | $16 → $18 | +11.80% | Sep 21, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $18 → $20 | Hold | Reiterates | $18 → $20 | +24.22% | Sep 21, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $33 | Buy | Maintains | $33 | +104.97% | Sep 18, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.